Today, a Major Shareholder at Vermillion, Henri George Schuler, exercised options of Vermillion (NASDAQ: VRML) for $792.2K.
This recent transaction increases Henri George Schuler’s holding in the company by 68.73% to a total of $8.04 million. In addition to Henri George Schuler, one other VRML executive reported Buy trades in the last month.
See today’s analyst top recommended stocks >>
The Company has a Price to Book ratio of 38.7597. Currently, Vermillion has an average volume of 89.83K.
Starting in February 2015, VRML received 19 Buy ratings in a row.
The insider sentiment on Vermillion has been positive according to 16 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Vermillion, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. The company’s bio-analytical solutions helps physicians diagnose, treat and improve gynecologic health outcomes for women.
